According to Gen Consulting Company, the global point-of-care molecular diagnostics market is set to achieve an incremental growth of USD 12.3 billion, acelerating at a CAGR of almost 14.7% during the forecast period 2022-2028.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global point-of-care molecular diagnostics market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the point-of-care molecular diagnostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, technology, application, and region. The global market for point-of-care molecular diagnostics can be segmented by application: infectious diseases, cancer, hematology, prenatal testing, endocrinology, others. The infectious diseases segment is estimated to account for the largest share of the global point-of-care molecular diagnostics market. Point-of-care molecular diagnostics market is further segmented by technology: PCR-based, microarray-based, hybridization-based, genetic sequencing-based. The PCR-based segment held the largest revenue share in 2021. Based on application, the point-of-care molecular diagnostics market is segmented into: decentralized lab, hospitals, household, assisted living facility, others. Globally, the decentralized lab segment made up the largest share of the point-of-care molecular diagnostics market. On the basis of region, the point-of-care molecular diagnostics market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global point-of-care molecular diagnostics market in 2021.

Market Segmentation
By application: infectious diseases, cancer, hematology, prenatal testing, endocrinology, others
By technology: PCR-based, microarray-based, hybridization-based, genetic sequencing-based
By application: decentralized lab, hospitals, household, assisted living facility, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The market research report covers the analysis of key stake holders of the global point-of-care molecular diagnostics market. Some of the leading players profiled in the report include Abbott Laboratories, Bio-Rad Laboratories, Inc., Quest Diagnostics, Inc., Roche Holding AG, Siemens AG, Danaher Corporation, BioMerieux SA, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global point-of-care molecular diagnostics market.
– To classify and forecast the global point-of-care molecular diagnostics market based on application, technology, application, region.
– To identify drivers and challenges for the global point-of-care molecular diagnostics market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global point-of-care molecular diagnostics market.
– To identify and analyze the profile of leading players operating in the global point-of-care molecular diagnostics market.

Why Choose This Report
– Gain a reliable outlook of the global point-of-care molecular diagnostics market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.